Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer episode artwork

EPISODE · May 20, 2024 · 1H 16M

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

from Oncology Today with Dr Neil Love

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published May 20, 2024

Embed this episode

NOW PLAYING

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

0:00 1:16:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 16 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on May 20, 2024.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!